SC Master Fund

SC Master Fund is a leading investment firm focusing on the venture capital stack. The SCMF invests in themed top-tier fund managers with information advantages and domain expertise localized in Southern California and direct investments with information asymmetry alongside top-tier VCs from our portfolio, network, or team's deal funnel. The fund covers advanced/frontier/emerging technologies applied to multiple verticals relevant to the SoCal & Global ecosystem. We have 100+ LPs ranging from CEOs to Corporations to Multigenerational Families to Foundations to SFOs/MFOs. Founded in 2020, the firm is headquartered in Corona Del Mar, CA.

Gregory Wertman

General Partner

7 past transactions

Higharc

Series B in 2024
Higharc, Inc. is a technology company based in Durham, North Carolina, founded in 2018. It offers a comprehensive web platform designed for homebuilders and new homebuyers, focusing on three-dimensional home design and customization. The platform allows users to create tailored home designs while managing plans, standards, and options within a single interface. It provides accurate materials lists and generates permit-ready construction documents, streamlining the building process. By enabling builders to design and sell homes in 3D, Higharc aims to enhance the efficiency of design, construction, and sales, ultimately reducing material waste and costly errors. The company's mission is to support builders in creating high-quality homes and communities in a more affordable manner.

Hyphen

Funding Round in 2022
Hyphen specializes in automating culinary operations for the restaurant and foodservice industry. The company develops a food technology solution aimed at reducing the cost of fresh food through the use of robotics. Their technology features modular hardware and reprogrammable software, which employs computer vision technology to assist restaurants in managing peak hours during lunch and dinner, while also preventing human errors in food preparation.

Anduril Industries

Series E in 2022
Anduril Industries is a defense technology company that designs, develops, and deploys hardware and software to address national security challenges for the United States and its allies. It offers the Lattice Platform, an AI-based system that fuses real-time data from computer vision, machine learning, and mesh networking into a single autonomous operating picture; Sentry Tower, which integrates data across the electromagnetic spectrum; Ghost sUAS, an unmanned autonomous, man-portable drone capable of performing missions with limited human intervention; and Anvil sUAS, a precision kinetic intercept that autonomously navigates to counter potential drone threats with visual verification by a human operator. Founded in 2017, Anduril is based in Irvine, California, with additional offices in Orange County, California; Washington, D.C.; and Seattle, Washington.

Renata Medical

Series B in 2022
Renata Medical specializes in developing innovative medical devices focused on addressing unmet needs in congenital heart disease. Their flagship product is an adjustable stent designed to grow with infants born with CHD, reducing the need for multiple invasive surgeries.

Slingshot Aerospace

Series A in 2021
Founded in 2016, Slingshot Aerospace develops mission-critical data and analytics solutions for the aerospace industry. Its platforms integrate global sensor data, artificial intelligence, and astrodynamics to enhance spaceflight awareness, reduce operational risk, and optimize decision-making for commercial and government space operators.

Sydnexis

Series B in 2021
Sydnexis is a biopharmaceutical company focused on developing a proprietary treatment for pediatric progressive myopia, which represents a significant unmet medical need globally. The company specializes in manufacturing a topical eyedrop formulation aimed at slowing the progression of myopia in children. By providing an innovative solution, Sydnexis enables healthcare professionals and institutions to effectively manage and reduce the incidence of myopia-related eye disorders in the pediatric population.

Renata Medical

Series A in 2020
Renata Medical specializes in developing innovative medical devices focused on addressing unmet needs in congenital heart disease. Their flagship product is an adjustable stent designed to grow with infants born with CHD, reducing the need for multiple invasive surgeries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.